EMERGENCY:A new severe headache, headache with fever and neck stiffness, headache with neurological signs (weakness, vision change, speech difficulty), or headache after head injury —call040-46324365immediately — 24 hours, 7 days— 24/7
Expert ICHD-3 diagnostic classification, headache diary review, medication overuse headache assessment and supervised withdrawal, amitriptyline and other preventive options, physiotherapy for pericranial tenderness, and lifestyle, stress, and workplace ergonomics counselling at KIMS Neuroscience, Secunderabad, Hyderabad.
Tension-type headache (TTH) is the most common primary headache disorder globally, affecting approximately 34–35% of Indian adults. It is characterised by bilateral pressing or tightening head pain — the classic 'tight band around the head' — mild to moderate in severity, not aggravated by physical activity, without significant nausea, and without both photophobia and phonophobia together. The most important clinical distinction: TTH is bilateral and pressing; migraine is typically unilateral and pulsating. Chronic TTH (15+ headache days per month for 3+ months) is driven most commonly by daily analgesic use — particularly codeine and caffeine combination tablets — and is entirely manageable once medication overuse is addressed and amitriptyline is started.
| Fact | Details |
|---|---|
| Definition | Bilateral pressing/tightening · Mild-moderate · Not aggravated by activity · No significant nausea · Not both photophobia and phonophobia together |
| India prevalence | 34–35% of adults · Hyderabad IT sector: screen use, poor sleep, caffeine overuse, occupational stress are documented drivers |
| Chronic TTH drivers | MOH (most important) · Poor sleep · Anxiety/depression · Pericranial muscle tenderness · Caffeine dependence |
| India-specific OTC culprits | Codeine/caffeine combination tablets (Saridon, Combiflam with additives) · Widely available OTC · Most common MOH drivers in Indian TTH population |
| Preventive therapy | Amitriptyline 10–75mg nocte (first-line) · Mirtazapine 15–30mg · Venlafaxine 75–150mg · Topiramate (if TTH + migraine co-exist) |
| Physiotherapy | Myofascial trigger point release · Cervical mobilisation · Deep cervical flexor strengthening · Workstation ergonomics for IT workers |
| Psychological | PHQ-9 and GAD-7 screening at KIMS · CBT for chronic headache + anxiety/depression · Amitriptyline addresses both TTH frequency and mood |
The essential facts that shape how TTH is recognised, classified, and managed at KIMS — from its high prevalence in India through the episodic-to-chronic transition driven by medication overuse to the critical clinical distinction between TTH and migraine.
The most common primary headache disorder globally, characterised by bilateral (both sides) pressing or tightening head pain, mild to moderate in severity, not aggravated by physical activity, without significant nausea, and without both photophobia and phonophobia together. The classic description: a tight band or vice-like pressure around the head. TTH is not accompanied by the neurological features of migraine (aura, severe nausea, significant light and sound sensitivity that prevents all activity).
TTH prevalence in India approximately 34–35% of adults in population-based studies — significantly more common than migraine. Most adults will experience TTH at some point in their lives. Chronic TTH (15 or more days per month for 3 months) affects approximately 2–3% of the population and is significantly disabling.
Infrequent episodic TTH: fewer than 1 day per month. Frequent episodic TTH: 1–14 days per month. Chronic TTH: 15 or more headache days per month for at least 3 months. The transition from episodic to chronic TTH is strongly associated with medication overuse (painkillers used more than 10–15 days per month) and with psychological co-morbidity (anxiety, depression).
TTH vs migraine. These two conditions coexist frequently — many patients have both. The distinction matters because their treatments are different: triptans work for migraine but not TTH; the treatment for TTH focuses on paracetamol or NSAIDs acutely, and amitriptyline for prevention of chronic TTH. The TTH vs migraine table on this page provides the clinical differentiation.
040-46324365
040-44885000
A 31-year-old software engineer in Hyderabad attends KIMS with a headache he has been having almost every day for the past 8 months. He works long hours on a screen, often skips lunch, drinks 5–6 cups of tea per day, and sleeps 5–6 hours per night. The headache is a pressure or tightening sensation across both sides of his head, like a band or helmet. It is present when he wakes up, worsens through the day, and is at its worst by evening. He rates it 4–5 out of 10. He can work through it, but barely. He takes a combination painkiller tablet (paracetamol + caffeine + codeine) every day, sometimes twice a day, because it is the only thing that takes the edge off.
At KIMS, the assessment is straightforward. The headache fits ICHD-3 criteria for chronic tension-type headache: bilateral, pressing quality, mild-to-moderate, not aggravated by activity, no significant nausea, without both photophobia and phonophobia together. There are no red flag features. His neck and shoulder muscles are tight on palpation. Crucially — he is using a combination analgesic containing codeine every day. This is medication overuse headache superimposed on chronic TTH.
The KIMS management plan has three parts: (1) supervised withdrawal of the codeine-combination analgesic; (2) starting amitriptyline 10mg at night, increasing to 25–50mg over 4 weeks; (3) addressing the lifestyle factors — screen breaks, sleep, caffeine reduction, and physiotherapy for cervicogenic contribution. At the 3-month review, his daily headache has reduced to 3–4 days per week and continues to improve.
This is the typical TTH presentation at KIMS — a common headache made chronic by daily analgesic use and sustained by lifestyle factors, entirely manageable with the right approach.
Book a Consultation
Speak directly with our headache specialist team — neurology, headache diary review, MOH supervised withdrawal, preventive medication, and physiotherapy coordinated under one roof. No referral required. Monday to Saturday.
040-44885000Emergency line: 040-46324365Many patients — and some clinicians — use the terms interchangeably. They are different conditions with different treatments. The cards below summarise the key distinguishing features across pain quality, location, severity, activity, autonomic and neurological features, and behaviour during attacks.
Tension-Type Headache: pressing / tightening / squeezing sensation, often described as a tight band or vice-like pressure around the head.
Migraine: pulsating / throbbing pain that often beats in time with the heart rate.
Pain quality alone is one of the most diagnostically reliable features distinguishing TTH from migraine.
Tension-Type Headache: bilateral (both sides) or band-like around the head.
Migraine: usually unilateral (one side); the side may switch between attacks.
A bilateral band-like pressing pain almost always points to TTH; a strictly one-sided pulsating pain points to migraine.
Tension-Type Headache: mild to moderate severity.
Migraine: moderate to severe severity.
Severity alone does not confirm either diagnosis but helps select appropriate first-line acute treatment.
Tension-Type Headache: not aggravated by routine physical activity — patients can often continue working through the headache.
Migraine: worsened by walking, climbing stairs, or routine physical activity.
Practical question used at KIMS: could you go for a walk during your headache without it becoming significantly worse? If yes, it is more likely TTH.
Tension-Type Headache: nausea is absent (may be mild in chronic TTH).
Migraine: nausea is present, sometimes with vomiting.
Significant nausea or vomiting accompanying head pain strongly favours migraine over TTH.
Tension-Type Headache: at most one of photophobia or phonophobia (not both).
Migraine: both photophobia and phonophobia present together during the attack.
Marked sensitivity to light AND sound together is a strong migraine feature.
Tension-Type Headache: no aura.
Migraine: aura is present in approximately 25% of migraine patients.
Reversible visual, sensory, or language disturbance lasting 5–60 minutes before the headache is migraine aura — never TTH.
Tension-Type Headache: no significant restlessness — patients often continue normal activities.
Migraine: prefers to lie still in a dark, quiet room.
Simple bedside observation of behaviour during an attack is highly informative for the TTH vs migraine distinction.
Many people with migraine also have TTH on some of their headache days. A patient may have 4–5 days of migraine per month and 10–12 days of TTH per month. At KIMS, a headache diary distinguishes which attacks are which, so each type receives its specific treatment. Triptans are used for migraine days; paracetamol or NSAIDs (within limits) for TTH days; and amitriptyline as a preventive addresses both.
Chronic tension-type headache is usually driven by a combination of medication overuse, poor sleep, psychological stressors, and musculoskeletal or postural strain. Identifying and correcting these drivers is central to the KIMS management strategy.
Using analgesics including paracetamol, NSAIDs, combination analgesics, or opioids on more than 15 days per month transforms episodic TTH into chronic daily headache.
The brain becomes sensitised and headache-dependent on the medication. This is called medication-overuse headache (MOH) or analgesic rebound.
In India, combination analgesics containing codeine or caffeine including Saridon, Combiflam with additives, and other over-the-counter combination tablets are among the most common culprits.
At KIMS, any patient with daily or near-daily headache is assessed for MOH as the first priority.
Inadequate sleep duration and disrupted sleep quality significantly lower the pain threshold and increase headache frequency.
In Hyderabad’s working population, 5–6 hours of sleep per night combined with late-night screen use is extremely common and is a major driver of chronic TTH.
Sleep hygiene counselling at KIMS includes consistent sleep and wake times seven days per week.
Blue-light screen avoidance for one hour before bed, maintaining a cool and dark sleep environment, and limiting caffeine after 2pm are specifically advised.
Anxiety disorders and depression are significantly more prevalent in patients with chronic TTH than in the general population.
The relationship is bidirectional: anxiety increases muscle tension and lowers pain threshold, while chronic daily headache itself produces helplessness, reduced activity, and depressive features.
At KIMS, psychological co-morbidity is specifically screened for using PHQ-9 for depression and GAD-7 for anxiety.
Psychological symptoms are treated alongside the headache itself — often amitriptyline addresses both headache frequency and mood symptoms.
Prolonged static neck and shoulder postures from desk work, screen use, and mobile phone use produce pericranial muscle tenderness and cervicogenic contribution to TTH.
On examination, the temporalis, trapezius, sternocleidomastoid, and suboccipital muscles are tender to palpation in most patients with chronic TTH.
Poor posture and sustained muscle contraction contribute significantly to the chronicity of headache symptoms.
Physiotherapy targeting neck and shoulder mobility, posture correction, and myofascial release forms an important component of the KIMS TTH management programme.
TTH is a clinical diagnosis based on ICHD-3 criteria. No investigations are needed for typical TTH in a patient with a long, stable pattern and no red flags. The KIMS pathway combines ICHD-3 confirmation, SNOOP4 red flag screening, headache diary review, pericranial tenderness assessment, and a structured MOH evaluation.
At least 10 prior episodes lasting 30 minutes to 7 days; bilateral location; pressing/tightening quality (not pulsating); mild-to-moderate severity; not aggravated by routine physical activity; no nausea or vomiting; not more than one of photophobia or phonophobia.
Systemic symptoms, Neurological signs, Onset (thunderclap or new severe), Older age, Pattern change, Postural features, Papilloedema, Pregnancy. Any red flag prompts MRI brain at KIMS. TTH is a clinical diagnosis: no investigations are needed for typical TTH in a patient with a long, stable pattern and no red flags.
1–3 months of diary recording (date, duration, severity, associated features, medications used) distinguishes TTH from migraine, quantifies frequency, and identifies medication overuse. The headache diary is the single most useful piece of information a patient can bring to a KIMS headache assessment.
Bilateral palpation of the temporalis, masseter, frontal, trapezius, and suboccipital muscles. Pericranial tenderness is present in most patients with TTH and helps distinguish it from migraine. TTH is subdivided into 'with pericranial tenderness' and 'without' — the former benefits particularly from physiotherapy.
Documenting analgesic use frequency. Identifying combination analgesics containing codeine or caffeine (Saridon, Combiflam with additives, and other combination tablets widely available OTC in India). Discussing the MOH cycle honestly with the patient. Without identifying and addressing MOH, preventive medications cannot work properly.
Supervised withdrawal of overused analgesics at KIMS. Patients are informed that the first 1–2 weeks of withdrawal typically produce a worsening of headache before improvement begins.
Strategies: abrupt withdrawal (for patients with strong motivation and a support plan) or tapering over 4 weeks; naproxen 500mg twice daily as a transitional medication during withdrawal; antiemetics for nausea; psychological support.
Approximately 50–60% of patients with MOH achieve significant headache improvement after supervised withdrawal. Without identifying and addressing MOH, preventive medications cannot work properly.
• Paracetamol 500–1000mg: First-line. Effective for mild TTH. Safe and well-tolerated. Should not be used on more than 2–3 days per week to avoid MOH.
• Ibuprofen 400–600mg or aspirin 900–1000mg: Effective for moderate TTH. NSAIDs slightly more effective than paracetamol for TTH. Should not be used on more than 2–3 days per week to avoid MOH.
• Combination analgesics: Paracetamol + caffeine combinations are marginally more effective acutely but carry a higher risk of caffeine-withdrawal headache and MOH. At KIMS, patients are counselled to avoid regular combination analgesics and codeine-containing tablets for TTH.
• Triptans: NOT effective for TTH. If a patient responds to sumatriptan, the headache was likely migraine. This is diagnostically useful at KIMS.
• Amitriptyline 10–75mg at night: the most evidence-based preventive for chronic TTH. A tricyclic antidepressant that reduces central sensitisation and improves sleep architecture alongside its antidepressant effect. Effective in approximately 30–40% of patients at adequate dose. Side effects: morning sedation (improves with dose adjustment), dry mouth, constipation, weight gain. Contraindicated in cardiac arrhythmia (ECG before starting in high-risk patients).
• Mirtazapine 15–30mg at night: an alternative when amitriptyline is not tolerated. Good sedative and appetite effects. KIMS uses this when amitriptyline causes excessive dry mouth or cardiac concerns.
• Venlafaxine 75–150mg daily: an SNRI with evidence for chronic TTH prevention. Particularly useful when TTH is co-morbid with anxiety or depression that has not responded to amitriptyline. Requires dose tapering when stopping.
• Topiramate 50–100mg/day: limited evidence for TTH, more robust evidence for migraine. Used at KIMS when TTH and migraine co-exist and a single preventive is preferred.
Cervical and shoulder mobilisation, myofascial trigger point release, postural correction for desk workers, strengthening of deep cervical flexors. At KIMS, physiotherapy referral is routine for chronic TTH patients with pericranial tenderness.
• Stress management and relaxation techniques: Diaphragmatic breathing, progressive muscle relaxation, biofeedback. Strong evidence for chronic TTH reduction. Cognitive Behavioural Therapy (CBT) for patients with co-morbid anxiety or depression and chronic headache.
• Sleep hygiene: Consistent sleep schedule. Screen avoidance 1 hour before bed. Caffeine cutoff at 2pm. Target 7–8 hours per night.
• Workplace ergonomics: Screen height, chair height, keyboard position. Hyderabad's IT workforce specifically benefits from formal workstation assessment.
Related Conditions
Tension-Type Headache belongs to the family of headache and pain syndromes evaluated and managed at KIMS Neuroscience:
The most common headache. The most often dismissed. Daily pain that has been there so long it feels normal. Chronic tension-type headache has a clear diagnosis, a clear treatment, and a clear path out — but the first step is a proper assessment rather than another painkiller from the pharmacy.
At KIMS Neuroscience, Secunderabad, Hyderabad, chronic tension-type headache is assessed with ICHD-3 criteria, headache diary analysis, medication overuse identification, and pericranial tenderness examination. Management includes supervised analgesic withdrawal where needed, amitriptyline or alternative preventive medication, physiotherapy for cervicogenic contribution, and sleep and lifestyle counselling. Both TTH and any co-existing migraine are diagnosed and addressed in the same consultation.
International enquiries: info@kimsneurosciences.com